Hana Pharm Co Ltd (293480) — Cash Flow-to-Debt Ratio
Hana Pharm Co Ltd (293480) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of ₩-1.41 Billion could theoretically repay 0% of its total liabilities (₩98.98 Billion) in one year. See 293480 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hana Pharm Co Ltd Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Hana Pharm Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see 293480 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Hana Pharm Co Ltd (2016–2024)
Year-by-year debt coverage analysis for Hana Pharm Co Ltd. Check how high is Hana Pharm Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.35x | ₩25.30 Billion | ₩72.83 Billion | ▲ +32.9% |
| 2023 | 0.26x | ₩18.40 Billion | ₩70.40 Billion | ▼ -34.3% |
| 2022 | 0.40x | ₩30.88 Billion | ₩77.57 Billion | ▼ -19.9% |
| 2021 | 0.50x | ₩25.66 Billion | ₩51.60 Billion | ▲ +41.1% |
| 2020 | 0.35x | ₩15.58 Billion | ₩44.20 Billion | ▼ -52.5% |
| 2019 | 0.74x | ₩31.72 Billion | ₩42.70 Billion | ▼ -0.4% |
| 2018 | 0.75x | ₩27.59 Billion | ₩36.99 Billion | ▲ +77.0% |
| 2017 | 0.42x | ₩25.38 Billion | ₩60.25 Billion | ▲ +99.8% |
| 2016 | 0.21x | ₩12.46 Billion | ₩59.11 Billion | — |